Osteoporosis News Archive

Denosumab Promising for TDT-Induced Osteoporosis Treatment

Denosumab Promising for TDT-Induced Osteoporosis Treatment

Denosumab may be beneficial for managing transfusion-dependent thalassemia-induced osteoporosis.

An Intermediary Role for Insulin Resistance in the Adipose-Bone Mass Relationship in Adolescents

An Intermediary Role for Insulin Resistance in the Adipose-Bone Mass Relationship in Adolescents

Insulin resistance may play an intermediary role in the relationship between adiposity and lumbar spine bone mass in adolescents.

Vitamin D Supplementation Has No Effect on Musculoskeletal Health

Vitamin D Supplementation Has No Effect on Musculoskeletal Health

There is little justification for the use of vitamin D supplements to maintain or improve musculoskeletal health.

Zoledronate Lowers Fracture Risk in Women With Osteopenia

Zoledronate Lowers Fracture Risk in Women With Osteopenia

The risk for fragility fractures is significantly lower in women with osteopenia who receive zoledronate than in those who receive placebo.

Fifteen Genetic Determinants of Fracture Identified

Fifteen Genetic Determinants of Fracture Identified

Fifteen genetic determinants of fracture, which are also associated with bone mineral density, have been identified.

Advanced Glycation End Products and esRAGE Predict Hip Fractures in Older Men

Advanced Glycation End Products and esRAGE Predict Hip Fractures in Older Men

Investigators assess whether circulating advanced glycation end products and esRAGE were associated with bone turnover and risk for fracture.

Poststroke Statin Therapy Associated With Lower Risk for Osteoporosis, Fractures

Poststroke Statin Therapy Associated With Lower Risk for Osteoporosis, Fractures

A variety of underlying mechanisms may be attributed to the role of statins in preventing bone-related disorders.

Lower Postoperative Mortality With Hip Fracture Surgery on Day of Admission

Lower Postoperative Mortality With Hip Fracture Surgery on Day of Admission

Postoperative mortality is lower for medically stable older patients who undergo surgery for hip fracture on the day of admission or the following day.

Influence of Weight Loss, Resistance Training, and Aerobic Training on Bone Health

Influence of Weight Loss, Resistance Training, and Aerobic Training on Bone Health

Investigators assessed the effect of exercise modality during dietary-induced on bone health.

Sedation Level After Hip Fracture Repair May Not Affect Delirium Risk

Sedation Level After Hip Fracture Repair May Not Affect Delirium Risk

For older patients undergoing hip fracture repair, the level of sedation does not affect delirium risk overall.

Real-World Data Show Reduced Fracture Rates in Teriparatide-Treated Osteoporosis

Real-World Data Show Reduced Fracture Rates in Teriparatide-Treated Osteoporosis

Rates of incident clinical vertebral fracture, incident nonvertebral fracture, hip fracture, and clinical fractures decreased 6 months after initiation of teriparatide.

Genetic Screening May Predict Osteoporosis and Fracture Risk

Genetic Screening May Predict Osteoporosis and Fracture Risk

Genetic testing may identify individuals with an increased risk for osteoporosis and bone fracture.

One-Third of Canadian Patients Get Hip Fracture Repair Within 24 Hours

One-Third of Canadian Patients Get Hip Fracture Repair Within 24 Hours

Only one-third of Canadian patients received hip fracture repair surgery within the desired 24 hours.

HbA1c-Corrected FRAX Score May Better Predict Fracture Risk in Type 2 Diabetes

HbA1c-Corrected FRAX Score May Better Predict Fracture Risk in Type 2 Diabetes

A corrected HbA1c factor may improve the ability to predict the risk for fracture by the FRAX algorithm in T2D.

Decreased Osteoporosis Treatment Initiation Observed After Hip Fracture

Decreased Osteoporosis Treatment Initiation Observed After Hip Fracture

Researchers observed a reduction in subsequent nonvertebral fracture rates in patients who initiated osteoporosis treatment.

Effect of Mediterranean Diet Plus Vitamin D3 on Bone Density in Osteoporosis

Effect of Mediterranean Diet Plus Vitamin D3 on Bone Density in Osteoporosis

Investigators examined the effect of consuming a Mediterranean-style diet for 1 year on inflammatory response and bone health in the elderly.

Empagliflozin Does Not Increase Fracture Risk in Type 2 Diabetes

Empagliflozin Does Not Increase Fracture Risk in Type 2 Diabetes

The risk for bone fractures was not increased in patients with type 2 diabetes using empagliflozin compared with placebo or glimepiride.

New Romosozumab BLA Includes Data From Additional Osteoporosis Trials

New Romosozumab BLA Includes Data From Additional Osteoporosis Trials

The Biologics License Application has been resubmitted for Evenity, an investigational treatment for osteoporosis in postmenopausal women at high risk for fracture.

Romosozumab: Effective in Men With Osteoporosis

Romosozumab: Effective in Men With Osteoporosis

Romosozumab increased spine and hip bone mineral density after 12 months of treatment.

Osteoporosis Fracture Risk Awareness Lacking in Postmenopausal Women

Osteoporosis Fracture Risk Awareness Lacking in Postmenopausal Women

Postmenopausal women have little awareness of osteoporotic fracture risk and poor understanding that a fragility fracture may be indicative of osteoporosis and that it increases future fracture risk.

USPSTF Favors Osteoporosis Screening to Prevent Fracture

USPSTF Favors Osteoporosis Screening to Prevent Fracture

Screening is recommended for women aged ≥65 years and younger women who have been through menopause and are at increased risk for osteoporosis.

Alendronate May Reduce Risk for CV Events After Hip Fracture

Alendronate May Reduce Risk for CV Events After Hip Fracture

Use of alendronate in individuals who experience a hip fracture is associated with a reduced risk for cardiovascular mortality, myocardial infarction, and stroke.

Serotonin Levels Predict Increased Risk for Hip Fracture, Nonvertebral Osteoporotic Fracture

Serotonin Levels Predict Increased Risk for Hip Fracture, Nonvertebral Osteoporotic Fracture

High levels of serotonin are predictive of an increased risk for hip fracture, nonvertebral osteoporotic fracture, and incident fractures in older men.

Romosozumab Followed by Denosumab Effective for BMD Increase in Postmenopausal Women

Romosozumab Followed by Denosumab Effective for BMD Increase in Postmenopausal Women

Romosozumab increased bone mineral density in postmenopausal women through increased bone formation and decreased bone resorption.

Higher Groin C Avidum Colonization in Obese Patients After Hip Arthroplasty

Higher Groin C Avidum Colonization in Obese Patients After Hip Arthroplasty

Researchers assessed the incidence of Cutibacterium avidum infection in patients following primary hip arthroplasty.

Examining Bone Microarchitecture, Strength in Older Men With Accelerated Bone Loss

Examining Bone Microarchitecture, Strength in Older Men With Accelerated Bone Loss

Men with accelerated bone loss have lower estimated bone strength, poorer trabecular microarchitecture, and thinner cortices compared with men without accelerated bone loss.

Associations Between Site-Specific BMD, Anthropometric, Glucose Homeostasis Traits

Associations Between Site-Specific BMD, Anthropometric, Glucose Homeostasis Traits

Negative effects of 2-hour glucose was pronounced at the cortical-bone-dominant sites in women.

Prolia Approved for Glucocorticoid-Induced Osteoporosis

Prolia Approved for Glucocorticoid-Induced Osteoporosis

The FDA has approved use of Prolia for the treatment of glucocorticoid-induced osteoporosis in men and women at high risk for fracture.

Effects of the 2 Types of Anorexia Nervosa on Bone Metabolism

Effects of the 2 Types of Anorexia Nervosa on Bone Metabolism

Investigators sought to determine whether both restrictive and purging types of anorexia nervosa effect bone metabolism.

Adverse Effect of Osteoporosis Drug May Help Treat Hair Loss

Adverse Effect of Osteoporosis Drug May Help Treat Hair Loss

An osteoporosis treatment may have a positive effect on human hair follicles from those undergoing hair transplantation surgery.

Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up

Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up

The 1-year cardiovascular mortality hazard ratio (HR) for alendronate users was 0.33 (95% CI, 0.17 to 0.65) and 0.55 for incident myocardial infarction (95% CI, 0.34 to 0.89).

Subclinical Thyroid Dysfunction Not Associated With Hip Fracture Risk in Older Men

Subclinical Thyroid Dysfunction Not Associated With Hip Fracture Risk in Older Men

Findings do not support a role for subclinical thyroid dysfunction as a biomarker for bone-related outcomes in older men.

Good Glycemic Control May Influence Bone Metabolism in Type 2 Diabetes

Good Glycemic Control May Influence Bone Metabolism in Type 2 Diabetes

Researchers showed that improved glycemic control is associated with higher bone resorption, possibly reflecting normalization rather than an abnormal increase in bone resorption.

Fracture Type Varies for Women With Anorexia and Oligo-Amenorrheic Athletes

Fracture Type Varies for Women With Anorexia and Oligo-Amenorrheic Athletes

A high stress fracture rate in oligo-amenorrheic athletes, who have whole body, less head and hip, areal bone mineral density (BMD) measures comparable to those of control patients, indicates that BMD in these women may need to be even higher to avoid fractures.

Hip Fracture Risk May Be Overestimated in Type 2 Diabetes

Hip Fracture Risk May Be Overestimated in Type 2 Diabetes

Researchers found that estimation of hip fracture risk without accounting for death as a competing event results in an overestimation of fracture risk.

Femoral Nerve Block Alone or in Combination With Sciatic Nerve Block for TKA: A Meta-Analysis

Femoral Nerve Block Alone or in Combination With Sciatic Nerve Block for TKA: A Meta-Analysis

Sciatic nerve block may represent an effective complement to femoral nerve block for total knee arthroplasty.

Crysvita Approved for the Treatment of X-Linked Hypophosphatemia

Crysvita Approved for the Treatment of X-Linked Hypophosphatemia

Crysvita is an antibody that blocks fibroblast growth factor 23 (FGF23), a hormone that causes phosphate urinary excretion and suppresses active vitamin D production by the kidney.

USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention

USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention

The USPSTF has released recommendations for vitamin D and calcium supplementation for the primary prevention of fractures in community-dwelling adults.

Diabetes Does Not Alter Anti-osteoporotic Treatment Response

Diabetes Does Not Alter Anti-osteoporotic Treatment Response

Anti-osteoporotic medications (mainly bisphosphonates) seem to equally prevent bone loss, especially in the lumbar spine, in patients with diabetes compared with patients without diabetes.

Multimodal Analgesia After Knee, Hip Arthroplasty and Perioperative Outcomes

Multimodal Analgesia After Knee, Hip Arthroplasty and Perioperative Outcomes

Multimodal analgesia after hip or knee arthroplasty may be associated with fewer complications and reduced opioid prescriptions and hospital length of stay, compared with unimodal analgesia.

Thiazide Diuretic Use May Reduce Risk for Bone Fracture

Thiazide Diuretic Use May Reduce Risk for Bone Fracture

Results from a meta-analysis found that thiazides have a significant protective effect on fracture risk.

Type 2 Diabetes Associated With Increased Fracture Risk in Postmenopausal Women

Type 2 Diabetes Associated With Increased Fracture Risk in Postmenopausal Women

Type 2 diabetes may be associated with an increased risk for a major osteoporotic fracture in postmenopausal women.

Increased Bone Formation in Osteoporosis With Teriparatide vs Zoledronic Acid

Increased Bone Formation in Osteoporosis With Teriparatide vs Zoledronic Acid

Treatment of osteoporosis with teriparatide is linked to greater bone formation compared with zoledronic acid.

Bariatric Surgery Associated With Risk for Nonvertebral Fractures

Bariatric Surgery Associated With Risk for Nonvertebral Fractures

Gastric bypass surgery was associated with increased risk for nonvertebral fractures.

Bone Mineral Density Assessed in Young Adults With Prader-Willi Syndrome

Bone Mineral Density Assessed in Young Adults With Prader-Willi Syndrome

Compared with growth hormone treatment, 1 year of placebo after attainment of adult height does not decrease bone mineral density in young adults with Prader-Willi syndrome.

SSRI Use Linked to Lower Bone Mass Density in Older Patients

SSRI Use Linked to Lower Bone Mass Density in Older Patients

SSRI use was found to be associated with reduced bone mineral density in the lumbar spine.

Community-Based Screening Cost-Effective for Osteoporotic Fracture Risk

Community-Based Screening Cost-Effective for Osteoporotic Fracture Risk

The SCOOP study evaluated screenings aimed at identifying older women who are at increased risk for fragility fractures.

Abaloparatide Treatment Evaluated in Elderly Women With Osteoporosis

Abaloparatide Treatment Evaluated in Elderly Women With Osteoporosis

Researchers examined the effects of abaloparatide in a subgroup of women older than 80 years from the ACTIVE trial.

Bone Mass and Microarchitecture Adversely Affected by Gastric Bypass Surgery

Bone Mass and Microarchitecture Adversely Affected by Gastric Bypass Surgery

Gastric bypass surgery can have damaging effects on bone mass as early as 6 months postoperatively.

Routine CT Scan May Predict Future Osteoporotic Fracture Risk

Routine CT Scan May Predict Future Osteoporotic Fracture Risk

Investigators sought to determine whether vertebral trabecular attenuation values measured on routine body CT scans can predict future osteoporotic fractures at multiple skeletal sites.

Denosumab Increases Bone Mineral Density in Women With Primary Hyperparathyroidism

Denosumab Increases Bone Mineral Density in Women With Primary Hyperparathyroidism

Treatment with denosumab may increase bone mineral density in older women with primary hyperparathyroidism-related osteoporosis.

Alogliptin May Be Associated With Lower Fracture Risk Compared With Linagliptin, Saxagliptin

Alogliptin May Be Associated With Lower Fracture Risk Compared With Linagliptin, Saxagliptin

Seventy-five randomized controlled trials were included in a meta-analysis comparing DDP-4 inhibitors with placebo and other diabetes medications.

Routine Vitamin D, Calcium Supplementation Not Associated With Fracture Reduction in Older Adults

Routine Vitamin D, Calcium Supplementation Not Associated With Fracture Reduction in Older Adults

Routine vitamin D and calcium supplementation in older adults is not supported for lowering the incidence of osteoporosis-related fractures.

Physical Activity Not Associated With Reduced Frailty Risk Among Sedentary, Older Adults

Physical Activity Not Associated With Reduced Frailty Risk Among Sedentary, Older Adults

Among older adults with functional limitations, a long-term physical activity program was not associated with reduced frailty risk.

Hip Fracture Risk Reduced With Certain Dairy Products, Fruits, Vegetables

Hip Fracture Risk Reduced With Certain Dairy Products, Fruits, Vegetables

Lower rates for hip fractures in women are linked to high intake of fermented milk products, along with fruits and vegetables.

Assessment of Risk for Venous Thromboembolism With Osteoporosis-Prevention Agents

Assessment of Risk for Venous Thromboembolism With Osteoporosis-Prevention Agents

The risk for venous thromboembolism among strontium ranelate, denosumab, teriparatide, alendronate, and other bisphosphonates was evaluated by investigators.

Delayed Hip Fracture Surgery Linked to Higher Mortality and Complications

Delayed Hip Fracture Surgery Linked to Higher Mortality and Complications

Hip fracture repair was linked to higher rates of 30-day mortality and post-operative complications when time between hospital arrival and surgery exceeded 24 hours.

Tocilizumab Reduces Bone Loss in ACPA-Positive Rheumatoid Arthritis

Tocilizumab Reduces Bone Loss in ACPA-Positive Rheumatoid Arthritis

Tocilizumab treatment for 2 years was shown to reduce levels of bone loss in patients with ACPA-positive RA.

Regional Nerve Block May Reduce Pain, Time to Mobilization After Hip Fracture

Regional Nerve Block May Reduce Pain, Time to Mobilization After Hip Fracture

In patients with hip fractures, the use of a regional nerve block may provide pain relief, and decrease the risk for pneumonia.

Bone Mineral Density Loss and Insulin Use in Women With Type 2 Diabetes

Bone Mineral Density Loss and Insulin Use in Women With Type 2 Diabetes

Rapid loss of bone density is linked with the use of insulin for T2D.

Growth Hormone Therapy May Reduce Fracture Risk in Postmenopausal Women With Osteoporosis

Growth Hormone Therapy May Reduce Fracture Risk in Postmenopausal Women With Osteoporosis

Growth hormone therapy may reduce the risk for fracture in patients with osteoporosis.

Prevention of Bone Loss in Patients With Epilepsy

Prevention of Bone Loss in Patients With Epilepsy

In patients with epilepsy, strict treatment is needed for the prevention of bone mineral density.

Adipose Tissue Associated With Bone Strength in Children, Adolescents

Adipose Tissue Associated With Bone Strength in Children, Adolescents

Greater visceral and/or subcutaneous adiposity may have an important role in bone growth during adolescence.

Lower Risk for New Fractures With Teriparatide Compared With Risedronate in Osteoporosis

Lower Risk for New Fractures With Teriparatide Compared With Risedronate in Osteoporosis

Investigators evaluated the efficacy of teriparatide vs risedronate in preventing clinical and vertebral fracture in post-menopausal women with existing vertebral fractures.

USPSTF Updates Osteoporosis Screening Recommendations for Fracture Prevention

USPSTF Updates Osteoporosis Screening Recommendations for Fracture Prevention

All women 65, high-risk postmenopausal women 65 should undergo bone measurement testing.

Bone Strength, BMD Assessment Cost-Effective for Postmenopausal Osteoporosis Screening

Bone Strength, BMD Assessment Cost-Effective for Postmenopausal Osteoporosis Screening

In postmenopausal women, assessment of bone strength and BMD is a cost-effective strategy of screening for osteoporosis.

Romosozumab Decreases Fracture Risk in Women With Osteoporosis Taking Alendronate

Romosozumab Decreases Fracture Risk in Women With Osteoporosis Taking Alendronate

In postmenopausal women at high risk for fracture, treatment with romosozumab for 12 months, followed by alendronate, was associated with significantly fewer hip fractures than treatment with alendronate alone.

Femoral Neck Bone Loss in Males Protected by High Dietary Fiber

Femoral Neck Bone Loss in Males Protected by High Dietary Fiber

Higher dietary fiber and fruit fiber is protective against bone loss at the femoral neck in men.

Vertebral Fracture Assessment vs Conventional Spine Radiography

Vertebral Fracture Assessment vs Conventional Spine Radiography

The use of vertebral fracture assessment has shown adequate performance for the detection of vertebral fractures.

Zoledronate Shows Prolonged Antiresorptive Activity in Postmenopausal Women With Osteopenia

Zoledronate Shows Prolonged Antiresorptive Activity in Postmenopausal Women With Osteopenia

Prolonged antiresorptive activity of ≥3 years has been associated with single zoledronate doses between 1 and 5 mg in postmenopausal women with osteopenia.

Incidence of New Fractures Reduced With Abaloparatide Followed by Alendronate

Incidence of New Fractures Reduced With Abaloparatide Followed by Alendronate

Tymlos is approved to treat postmenopausal women with osteoporosis at high risk for fracture.

Incident Radiographic Vertebral Fractures Associated with Back Pain in Older Men

Incident Radiographic Vertebral Fractures Associated with Back Pain in Older Men

Clinically undiagnossed radiographic VFs are linked to increased back pain symptoms.

Osteoporotic Fractures, Diabetes Complications Similarly Affect QoL

Osteoporotic Fractures, Diabetes Complications Similarly Affect QoL

Quality of life is similarly impacted by osteoporotic fractures and complications of diabetes.

Evenity Reduces Risk of New Fractures in Postmenopausal Women With Osteoperosis

Evenity Reduces Risk of New Fractures in Postmenopausal Women With Osteoperosis

Evenity followed by alendronate is better at reducing fracture risk in postmenopausal women.

BMD in Menopause Improved With OSA-Related Hypoxia

BMD in Menopause Improved With OSA-Related Hypoxia

The risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

Heart Failure, Arrhythmia Risk Increased With Zoledronic Acid

Patients had a higher risk for heart failure, among other cardiovascular conditions, if treated with zoledronic acid.

Hypoxia in OSA Lowers Risk of Bone Health Decline in Menopausal Women

Hypoxia in OSA Lowers Risk of Bone Health Decline in Menopausal Women

Risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.

Relationship of BMD and Physical Activity in Class III Obesity

Relationship of BMD and Physical Activity in Class III Obesity

In people with class III obesity, variance in femoral neck BMD can be determined by time spent doing light physical activity.

Do Depression, Anxiety Affect BMD in Anorexia?

Do Depression, Anxiety Affect BMD in Anorexia?

Anxiety and depression are associated with low BMD in anorexia patients.

Prediction of Fractures and CV Events With Serum Osteoprotegerin Levels

Prediction of Fractures and CV Events With Serum Osteoprotegerin Levels

Following adjustment, fracture risk was highest among patients in the lowest osteoprotegerin levels.

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

To improve pain relief, surgeons should proactively address stress, distress, and ineffective coping strategies.

K-Postn May Be Predictor of Fx Risk in Postmenopausal Women Independent of BMD and FRAX

K-Postn May Be Predictor of Fx Risk in Postmenopausal Women Independent of BMD and FRAX

K-Postn may serve as a predictor of incident low-trauma fractures in postmenopausal women.

Marrow Fat May Determine Bone Metabolism After Roux-en-Y Gastric Bypass

Marrow Fat May Determine Bone Metabolism After Roux-en-Y Gastric Bypass

Marrow fat may determine bone mass after Roux-en-Y gastric bypass.

Denosumab Discontinuation for Osteoporosis: What Are the Risks?

Denosumab Discontinuation for Osteoporosis: What Are the Risks?

Discontinuing denosumab therapy in osteoporosis may increase the risk for vertebral fractures.

BMD Increased by Romosozumab in Women Transitioning From Bisphosphonates

BMD Increased by Romosozumab in Women Transitioning From Bisphosphonates

Romosozumab could be a better option than teriparatide for patients at a high risk for fracture.

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal Women

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal Women

Fracture risk is able to be predicted as long as 25 years by a single BMD and fracture history assessment.

Osteoporosis Meds Increase BMD in Nonmetastatic Prostate Cancer

Osteoporosis Meds Increase BMD in Nonmetastatic Prostate Cancer

Osteoporosis medications are increasing BMD in men with nonmetastatic prostate cancer who are receiving ADT.

Hip, Spine BMD Decline Slowed By Deferred Antiretroviral Therapy

Hip, Spine BMD Decline Slowed By Deferred Antiretroviral Therapy

The clinical benefits of beginning ART early outweigh the decrease outcomes related to bone mineral density.

Osteoporosis Tx Romosozumab Continues License Application

Osteoporosis Tx Romosozumab Continues License Application

The FDA has published a Complete Response Letter in reply to the BLA for romosozumab.

Review Addresses Optimal Care of Type 2 Diabetes and Osteoporosis

Review Addresses Optimal Care of Type 2 Diabetes and Osteoporosis

Scientific evidence should be considered in optimal management of coexisting T2D and osteoporosis.

Lower Risk for Hip Fracture With Alendronate Use Among Older Patients

Lower Risk for Hip Fracture With Alendronate Use Among Older Patients

Alendronate treatment was associated with a significantly lower risk for hip fracture among older patients.

FDA Approves Abaloparatide for Fragility Fracture in Postmenopausal Osteoporosis

FDA Approves Abaloparatide for Fragility Fracture in Postmenopausal Osteoporosis

Approval was based on the results of the ACTIVE and ACTIVExtension trials.

Osteoporosis More Likely in Multiple Sclerosis

Osteoporosis More Likely in Multiple Sclerosis

Osteoporosis was more prevalent in patients with MS compared with matched controls.

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause

Bone mineral density was statistically different from baseline after 24 months.

HIV-Induced Osteoporosis Detected Via Bone Ultrasonography

HIV-Induced Osteoporosis Detected Via Bone Ultrasonography

Bone ultrasonography was able to detect tenofovir-induced bone loss in patients with HIV.

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

Case study of an 83-year-old male patient who developed severe hypocalcemia induced by denosumab.

Cadmium Exposure Through Diet Increases Risk of Osteoporosis

Cadmium Exposure Through Diet Increases Risk of Osteoporosis

This study shows that populations exposed to more cadmium in their diet were at a disproportionately increased risk of developing osteoporosis.

Low Level of Physical Activity May Cut Fracture Risk

Low Level of Physical Activity May Cut Fracture Risk

There was a lower rate of fracture for individuals who walked or bicycled less than 20 minutes/day vs hardly ever.

Testosterone Treatment Increases Bone Density, Strength in Older Men

Testosterone Treatment Increases Bone Density, Strength in Older Men

Testosterone replacement therapy may help improve bone mineral density and strength in older men.

Osteoporosis Treatment Receives Updated Guidelines From ACP

Osteoporosis Treatment Receives Updated Guidelines From ACP

The American College of Physicians has updated its 2008 guidelines on treating low bone density and osteoporosis to prevent fractures.

Sign Up for Free e-newsletters